Health Care & Life Sciences » Pharmaceuticals | Johnson & Johnson CEDEAR

Johnson & Johnson CEDEAR | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
29,206
33,089
38,376
41,907
18,296
Total Accounts Receivable
11,713
10,985
10,734
11,699
13,490
Inventories
7,878
8,184
8,053
8,144
8,765
Other Current Assets
7,610
7,053
3,047
3,282
2,537
Total Current Assets
56,407
59,311
60,210
65,032
43,088
Net Property, Plant & Equipment
16,710
16,126
15,905
15,912
17,005
Total Investments and Advances
333
679
1,494
1,209
751
Intangible Assets
50,745
49,054
47,393
49,681
85,134
Other Assets
4,616
2,553
2,919
3,226
4,220
Total Assets
132,683
131,119
133,411
141,208
157,303
ST Debt & Current Portion LT Debt
4,852
3,638
7,004
4,684
3,906
Accounts Payable
6,266
7,633
6,668
6,918
7,310
Income Tax Payable
770
500
750
971
1,854
Other Current Liabilities
13,787
13,314
13,325
13,714
17,467
Total Current Liabilities
25,675
25,085
27,747
26,287
30,537
Long-Term Debt
13,328
15,122
12,857
22,442
30,675
Provision for Risks & Charges
7,784
9,972
8,854
9,615
10,074
Deferred Taxes
117
242
2,928
3,238
1,263
Other Liabilities
7,854
8,034
10,241
9,536
17,489
Total Liabilities
58,630
61,367
62,261
70,790
97,143
Common Equity (Total)
74,053
69,752
71,150
70,418
60,160
Total Shareholders' Equity
74,053
69,752
71,150
70,418
60,160
Total Equity
74,053
69,752
71,150
70,418
60,160
Liabilities & Shareholders' Equity
132,683
131,119
133,411
141,208
157,303

About Johnson & Johnson CEDEAR

View Profile
Address
One Johnson & Johnson Plaza
New Brunswick New Jersey 08933
United States
Employees -
Website http://www.jnj.com
Updated 09/14/2018
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets.